TSMC Japan's Second Fab to Produce 3nm Chips by 2028 
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant 
Federal Judge Blocks Pentagon's Blacklisting of AI Company Anthropic 
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments 
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand 
Luxury Car Sales in the Middle East Take a Hit Amid Iran War 
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth 
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers 
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO 
Apple Turns 50: From Garage Startup to AI Crossroads 
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push 
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal 
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs 
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore 
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal 
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth 
FORT LAUDERDALE, Fla., Aug. 31, 2017 -- OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced that it has received certification approval from the U.S. Department of Commerce for the EU-U.S. Privacy Shield Framework program and the Swiss-U.S. Privacy Shield Framework, the successors to the U.S.-EU and U.S.-Swiss Safe Harbor Frameworks.
“This is an important achievement,” said Djuro Blanuscha, OmniComm Europe GmbH’s data protection officer. “We have made great efforts to implement the high European data protection standards throughout the entire company, and we will continue to work to ensure compliance with the related regulations in the future.”
The U.S. Department of Commerce and the European Commission developed the EU-U.S. Privacy Shield and the Swiss-U.S. Privacy Shield Frameworks “to provide companies on both sides of the Atlantic with a mechanism to comply with data protection requirements when transferring personal data from the European Union and Switzerland to the United States in support of transatlantic commerce,” according to a statement from the Privacy Shield program.
The Privacy Shield has replaced the U.S.-EU Safe Harbor Program, which was invalidated in October of 2015. More information about the Privacy Shield can be found at: https://www.privacyshield.gov
“OmniComm values and respects the confidentiality and the protection of personal data. With our commitment to comply with Privacy Shield requirements, we assure our European clients and partners that their personal information is handled in adherence to the strict European data privacy principles when it is transferred to the U.S.,” said Yvonne Rollinger, Ph.D., managing director of OmniComm Europe GmbH.
About OmniComm Systems, Inc.
OmniComm Systems, Inc. is a leading strategic software solutions provider to the life sciences industry. OmniComm is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, these organizations drive efficiency in clinical development, better manage their risks, ensure regulatory compliance and manage their clinical operations performance. With an extensive global experience from more than 5,000 clinical trials, OmniComm provides comprehensive solutions for clinical research. For more information, visit: www.omnicomm.com
Trademarks
OmniComm, TrialMaster, TrialOne, and Promasys are registered trademarks of OmniComm Systems, Inc. Other names may be trademarks of their respective owners.
Contact Info Kuno van der Post OmniComm Systems, Inc. +1.954.473.1254 [email protected]
